Posted by admin on May 14th, 2022

Shares of Bath & Body Works, Inc. (NYSE:BBWI – Get Rating) have earned an average rating of “Buy” from the twenty brokerages that are currently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation, fifteen have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $78.82.

A number of equities research analysts recently weighed in on the stock. Cowen raised shares of Bath & Body Works from a “market perform” rating to an “outperform” rating in a report on Monday, May 2nd. The Goldman Sachs Group raised shares of Bath & Body Works from a “buy” rating to a “conviction-buy” rating in a report on Wednesday, January 19th. Wells Fargo & Company lowered their price target on shares of Bath & Body Works from $85.00 to $70.00 and set an “overweight” rating for the company in a report on Tuesday, April 5th. BMO Capital Markets lowered their price target on shares of Bath & Body Works from $90.00 to $83.00 and set an “outperform” rating for the company in a report on Thursday, February 24th. Finally, Credit Suisse Group decreased their price objective on shares of Bath & Body Works from $69.00 to $64.00 and set a “neutral” rating for the company in a report on Friday, February 25th.

Bath & Body Works stock opened at $51.01 on Friday. Bath & Body Works has a 52-week low of $44.17 and a 52-week high of $82.00. The firm has a fifty day moving average of $50.34 and a 200-day moving average of $59.71. The firm has a market capitalization of $12.17 billion, a P/E ratio of 10.37, a PEG ratio of 1.12 and a beta of 1.56.

Bath & Body Works (NYSE:BBWI – Get Rating) last released its quarterly earnings data on Wednesday, February 23rd. The company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.03. The company had revenue of $3.03 billion during the quarter, compared to analyst estimates of $2.96 billion. Bath & Body Works had a net margin of 14.13% and a negative return on equity of 115.32%. The business’s quarterly revenue was up 11.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.96 earnings per share. Sell-side analysts forecast that Bath & Body Works will post 4.62 earnings per share for the current fiscal year.

In other news, CFO Wendy C. Arlin sold 6,000 shares of the firm’s stock in a transaction dated Tuesday, April 19th. The shares were sold at an average price of $55.00, for a total value of $330,000.00. Following the transaction, the chief financial officer now directly owns 98,888 shares in the company, valued at approximately $5,438,840. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 0.37% of the company’s stock.

A number of large investors have recently modified their holdings of BBWI. Prospera Financial Services Inc bought a new stake in Bath & Body Works in the 1st quarter valued at about $25,000. Northwestern Mutual Wealth Management Co. increased its stake in Bath & Body Works by 119.7% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 525 shares of the company’s stock valued at $26,000 after buying an additional 286 shares during the period. Acadian Asset Management LLC acquired a new position in Bath & Body Works during the 4th quarter valued at about $30,000. First Horizon Advisors Inc. increased its stake in Bath & Body Works by 361.4% during the 1st quarter. First Horizon Advisors Inc. now owns 646 shares of the company’s stock valued at $31,000 after buying an additional 506 shares during the period. Finally, CX Institutional acquired a new position in Bath & Body Works during the 3rd quarter valued at about $34,000. Hedge funds and other institutional investors own 97.11% of the company’s stock.

Bath & Body Works Company Profile (Get Rating)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.

RiceBran Technologies (NASDAQ:RIBT) Short Interest Update